Results 71 to 80 of about 3,729,528 (319)

Candidate Biomarkers to Distinguish Spinal Tuberculosis From Mechanical Back Pain in a Tuberculosis Endemic Setting [PDF]

open access: gold, 2021
Theresa N. Mann   +6 more
openalex   +1 more source

The Impact of Chronic Discogenic Low Back Pain: Costs and Patients' Burden

open access: yesPain Research and Management, 2018
Introduction Chronic discogenic low back pain (CDP) is frequently diagnosed in patients referred to specialized pain clinics for their back pain.
J. Geurts   +4 more
semanticscholar   +1 more source

Lived and Care Experiences of Chronic Musculoskeletal Shoulder Pain in Australian Adults: A Qualitative Study

open access: yesArthritis Care &Research, EarlyView.
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli   +8 more
wiley   +1 more source

Acute back pain

open access: yesМедицинский совет, 2016
In most cases, back pain is caused by inflammation of the spinal muscles and joints, and periarticular soft tissues. The pain is benign, and the patients may experience spontaneous remission (in half of cases within a week, in 90% of cases within a month)
A. N. Barinov   +2 more
doaj   +1 more source

Open-label placebo treatment in chronic low back pain: a randomized controlled trial

open access: yesPain, 2016
This randomized controlled trial was performed to investigate whether placebo effects in chronic low back pain could be harnessed ethically by adding open-label placebo (OLP) treatment to treatment as usual (TAU) for 3 weeks.
Cláudia Carvalho   +5 more
semanticscholar   +1 more source

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

open access: yesArthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry   +16 more
wiley   +1 more source

Short-Term Effects of NO2 Exposure on Hospitalization for Chronic Kidney Disease

open access: yesToxics
This study investigates the correlation between short-term exposure to nitrogen dioxide (NO2) and hospitalization for chronic kidney disease (CKD) in Lanzhou, China.
Wancheng Zhang, Ye Ruan, Jianglong Ling
doaj   +1 more source

Back Pain: Management & Controversies [PDF]

open access: yesThe Indian Anaesthetists' Forum, 2001
Back pain is the second most frequent chronic pain problem, just after headache, as a reason for patients to seek medical help. Suffering from back pain ranges from transient discomfort to frank incapacitation.
Dr Surendra Bhutra
doaj  

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

open access: yesArthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy